Presentation
International Hospital Diabetes Meeting
Date
May 2015
Authors
Melanie Mabrey, Joseph Aloi, Paul Chidester, Amy Henderson, Raymie McFarland, Robby Booth, Andrew Rhinehart
Objective
The American Diabetes Association guidelines recommend a basal bolus correction insulin regimen as the preferred method of treatment for non-critically ill hospitalized patients. The targets for pre-meal blood glucose (BG) of <140 mg/dL and random BG of <180 mg/dL are well defined. However, achieving these targets safely, without hypoglycemia, is challenging. In this stud we evaluated BG control before and after Glucommander (GM) subcutaneous treatment for patients outside of the intensive care unit.
Methods
Results
Conclusion
Patients using GM SubQ achieved improved glycemic control with lower incidence of hypoglycemia (<70 mg/dL) compared to both Before and After GM management. These results suggest that GM can safely maintain glucose control with less hypoglycemia than standard basal bolus treatment.